The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives.
PhRMA's mission is to conduct effective advocacy for public policies that encourage discovery of important new medicines for patients by pharmaceutical/biotechnology research companies.
PhRMA is a strong supporter of intellectual property laws. As CEO Billy Tauzin explains: "These efforts are an essential part of maintaining global incentives for research and development into new medicines. Protecting American intellectual property is important to the U.S. economy. Worldwide respect for intellectual property is the engine that will enable patients around the globe to receive the benefits of future discoveries of life-saving prescription medicines."
